B9 – E-cigs, Vaping, Electronic Nicotine Delivery Systems (ENDs) — What Providers Need to Know
Monday, May 3, 2021
3:00 PM – 3:45 PM EDT
Growing research shows that use of electronic nicotine delivery systems among behavioral health populations has significantly increased in the past few years – behavioral health populations are almost three times as likely to try vaping and/or e-cigarettes. What does the latest evidence-based research have to say about the emerging trends, challenges and health implications that are specific to behavioral health populations? Find out whether these new tobacco delivery mechanisms are viable cessation or harm reduction methods and the latest in treatment and policies as they apply to behavioral health settings.
- Describe the disparities, data and implications of vaping for adults and youth with mental health and substance use disorders.
- Develop a greater understanding of the short and long-term impact of ENDs, e-cigarette/vaping use and nicotine on behavioral health populations.
- Describe the science and regulatory process behind e-cigarette/vaping ENDs.
- Identify the resource to effectively prevent and treat END usage with behavioral health populations and specific resources on how to engage youth in preventing e cigarette/vaping ENDs use.
- FDA “The Real Cost” Youth E-Cigarette Prevention Campaign
- Vaporizers, E-Cigarettes, and other Electronic Nicotine Delivery Systems (ENDS)
- FDA Commits to Evidence-Based Actions Aimed at Saving Lives and Preventing Future Generations of Smokers
- FDA’s Youth Tobacco Prevention Plan
- FDA Center for Tobacco Products Exchange Lab
- Smoke-free Teen
- NBHN Youth Vaping Resource Guide
- I COVID Quit Campaign
- Implementation Toolkit for Statewide Tobacco Control Programs